Dynamic contrast-enhanced perfusion MR imaging measurements of endothelial permeability: differentiation between atypical and typical meningiomas.

BACKGROUND AND PURPOSE The measurement of relative cerebral blood volume (rCBV) and the volume transfer constant (K(trans)) by means of dynamic contrast-enhanced (DCE) perfusion MR imaging (pMRI) can be useful in characterizing brain tumors. The purpose of our study was to evaluate the utility of these measurements in differentiating typical meningiomas and atypical meningiomas. METHODS Fifteen patients with pathologically confirmed typical meningiomas and seven with atypical meningiomas underwent conventional imaging and DCE pMRI before resection. rCBV measurements were calculated by using standard intravascular indicator dilution algorithms. K(trans) was calculated from the same DCE pMRI data by using a new pharmacokinetic modeling (PM) algorithm. Results were compared with pathologic findings. RESULTS Mean rCBV was 8.02 +/- 4.74 in the 15 typical meningiomas and 10.50 +/- 2.1 in the seven atypical meningiomas. K(trans) was 0.0016 seconds(-1) +/- 0.0012 in the typical group and 0.0066 seconds(-1) +/- 0.0026 in the atypical group. The difference in K(trans) was statistically significant (P <.01, Student t test). Other parameters generated with the PM algorithm (plasma volume, volume of the extravascular extracellular space, and flux rate constant) were not significantly different between the two tumor types. CONCLUSION DCE pMRI may have a role in the prospective characterization of meningiomas. Specifically, the measurement of K(trans) is of use in distinguishing atypical meningiomas from typical meningiomas.

[1]  C. Wilson,et al.  Meningiomas: genetics, malignancy, and the role of radiation in induction and treatment. The Richard C. Schneider Lecture. , 1994, Journal of neurosurgery.

[2]  P. Tofts.  Modeling tracer kinetics in dynamic Gd‐DTPA MR imaging , 1997, Journal of magnetic resonance imaging : JMRI.

[3]  W. Simpson,et al.  Radiotherapy for atypical or malignant intracranial meningioma. , 1996, International journal of radiation oncology, biology, physics.

[4]  N. Barbaro,et al.  Radiation therapy in the treatment of partially resected meningiomas. , 1987, Neurosurgery.

[5]  Glyn Johnson,et al.  Relative cerebral blood volume measurements in intracranial mass lesions: interobserver and intraobserver reproducibility study. , 2002, Radiology.

[6]  B. Scheithauer,et al.  Meningioma grading: an analysis of histologic parameters. , 1997, The American journal of surgical pathology.

[7]  K. Jellinger,et al.  Histological subtypes and prognostic problems in meningiomas , 2004, Journal of Neurology.

[8]  H. Budka,et al.  Classic, atypical, and anaplastic meningioma: three histopathological subtypes of clinical relevance. , 1992, Journal of neurosurgery.

[9]  G. Giles,et al.  Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator , 1993, Histopathology.

[10]  A. Mahmood,et al.  Atypical and malignant meningiomas: a clinicopathological review. , 1993 .

[11]  R. Mirimanoff,et al.  The role of radiotherapy in the treatment of subtotally resected benign meningiomas , 1992, Journal of Neuro-Oncology.

[12]  T. Hirai,et al.  Dynamic MRI of meningiomas and schwannomas: is differential diagnosis possible? , 1997, Neuroradiology.

[13]  W. Henn,et al.  Triple approach for diagnosis and grading of meningiomas: Histology, morphometry of Ki-67/feulgen stainings, and cytogenetics , 2005, Acta Neurochirurgica.

[14]  W. K. Alfred Yung.  PATHOLOGY AND GENETICS OF TUMOURS OF THE NERVOUS SYSTEM , 2002 .

[15]  W. Friedman,et al.  The meningioma controversy: postoperative radiation therapy. , 1988, International journal of radiation oncology, biology, physics.

[16]  A. Sorensen,et al.  Comparison of permeability in high-grade and low-grade brain tumors using dynamic susceptibility contrast MR imaging. , 2002, AJR. American journal of roentgenology.

[17]  Jia-Hong Gao,et al.  Perfusion MRI Evaluation of Correlating Perfusion Constants with Histologic Findings in Meningiomas , 2002 .

[18]  B. Rosen,et al.  Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.

[19]  Y Yonekura,et al.  Vascular permeability: quantitative measurement with double-echo dynamic MR imaging--theory and clinical application. , 2000, Radiology.

[20]  C. Lohse,et al.  “MALIGNANCY” IN MENINGIOMAS: A CLINICOPATHOLOGIC STUDY OF 116 PATIENTS WITH GRADING IMPLICATIONS , 1999 .

[21]  G. Barnett,et al.  Frozen section evaluation of stereotactic brain biopsies: diagnostic yield at the stereotactic target position in 188 cases. , 1997, Archives of pathology & laboratory medicine.

[22]  H. Dvorak,et al.  Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. , 1999, Current topics in microbiology and immunology.

[23]  W. Hall.  The safety and efficacy of stereotactic biopsy for intracranial lesions , 1998, Cancer.

[24]  G Johnson,et al.  Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. , 1999, Radiology.

[25]  G. Crisi,et al.  MRI of intracranial meningiomas: correlations with histology and physical consistency , 1993, Neuroradiology.

[26]  E F Halpern,et al.  Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. , 1994, Radiology.

[27]  W P Dillon,et al.  Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. , 2000, AJNR. American journal of neuroradiology.

[28]  D. Long.  Vascular ultrastructure in human meningiomas and schwannomas. , 1973, Journal of neurosurgery.